Reviva Pharmaceuticals Holdings Inc's Customers Performance

Name: Reviva Pharmaceuticals Holdings Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

RVPH

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


RVPH's Source of Revenues		• List of RVPH Customers

for the same period Reviva Pharmaceuticals Holdings Inc

• List of RVPH Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Reviva Pharmaceuticals Holdings Inc's Comment on Sales, Marketing and Customers

News about Reviva Pharmaceuticals Holdings Inc Contracts

Reviva Pharmaceuticals Unveils Promising Vocal Biomarker Data from Phase 3 RECOVER Trial, Supporting the Efficacy of ...

Vocal Biomarker Data Highlights Efficacy of Brilaroxazine in Schizophrenia Treatment: Insights from the Phase 3 RECOVER Trial Reviva Pharmaceuticals Holdings Inc. has made significant strides in the pharmacological treatment of schizophrenia, as evidenced by the recent announcement of novel vocal biomarker data derived from the Phase 3 RECOVER trial evaluating brilaroxazine. The trial s findings indicate statistically significant speech latency data, underlining the robust efficacy of brilaroxazine, particularly in addressing negative symptoms and other critical symptom domains associated with schizophrenia.Schizophrenia remains a complex mental health disorder characterized by a spectrum of symptoms, includ...

Revivas Brilaroxazine A Promising Solution Encompassing the Complexity of Pulmonary Hypertension in Divers...

CSIMarket.com is pleased to present a groundbreaking article that highlights the recent European patent grant covering the use of brilaroxazine for the treatment of pulmonary hypertension (PH). This patent encompasses the treatment of not only PH but also pulmonary arterial hypertension (PAH) in all patients, including those suffering from chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD).Pulmonary hypertension is a debilitating condition characterized by elevated blood pressure in the pulmonary arteries, leading to significant strain on the heart and lungs. PAH, a subtype of PH, specifically affects the arteries connecting the heart and lungs, resulting in further deterioration of ...

Reviva's Brilaroxazine Paves the Way for Enhanced Schizophrenia Treatment, with Encouraging Enrollment Update and Insightful KOL Event

Reviva s Brilaroxazine Continues to Show Promise in Schizophrenia Treatment StudyReviva Pharmaceuticals, Inc. has recently provided an enrollment update for its open-label extension study evaluating Brilaroxazine in schizophrenia. With 358 patients enrolled and 223 currently receiving treatment across sites in the USA, Europe, and Asia, the study is progressing well.The company has been diligently working towards advancing the understanding and treatment of schizophrenia. In addition to the enrollment update, Reviva has also announced a virtual Key Opinion Leader (KOL) event to discuss the topline data from the Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia. This event, scheduled for Thursday, Febru...

RVPH's Stock Performance relative to it's Customers

RVPH's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Reviva Pharmaceuticals Holdings Inc	3.30	0.00	-16.63	14
SUBTOTAL	0.00	0.00	0.00	-

Sources: Reviva Pharmaceuticals Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Reviva Pharmaceuticals Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Reviva Pharmaceuticals Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.